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Background: Gastrointestinal (GI) symptoms are common in patients with eating disorders. The aim of this study
was to determine, using factor analysis, whether these GI symptom factors (clusters) in eating disorder patients hold
true to the Rome II classification of functional gastrointestinal disorders (FGIDs).
Methods: Inpatients in a specialised eating disorder unit completed the Rome II questionnaire. Data from 185
patients were analysed using factor analysis of 17 questions cited as present in 30% to 70% of the patients.
Results: Five factors emerged accounting for 68% of the variance and these were termed: ‘oesophageal
discomfort’, ‘bowel dysfunction’, ‘abdominal discomfort’, ‘pelvic floor dysfunction’, and ‘self-induced vomiting’. These
factors are significantly related to the Rome II FGID categories of functional oesophageal, bowel and anorectal
disorders, and to the specific FGIDs of IBS, functional abdominal bloating, functional constipation and pelvic floor
dyssynergia. Both heartburn and chest pain were included in the oesophageal discomfort factor. The ‘pelvic floor
dysfunction’ factor was distinct from functional constipation.
Conclusions: The GI symptoms common in eating disorder patients very likely represent the same FGIDs that
occur in non-ED patients. Symptoms of pelvic floor dysfunction in the absence of functional constipation, however,
are prominent in eating disorder patients. Further investigation of the items comprising the ‘pelvic floor
dysfunction’ factor in other patient populations may yield useful results.
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The functional gastrointestinal disorders (FGIDs) are
biopsychosocial disorders which, like other such disor-
ders for example eating disorders (ED), present difficul-
ties in assessment and measurement [1,2]. Description
and categorization of the FGIDs according to the Rome
criteria [3] presupposes that clusters of symptoms hold
true across different populations; this is despite the fact
that the presentation and form of these disorders are
affected by a wide range of factors, including physical
and psychological comorbidity [4,5].* Correspondence: suzanne.abraham@sydney.edu.au
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distribution, and reproduction in any mediumFactor analysis (confirmatory) seeks to determine if
the factors (collections of measured symptoms) confirm
what is expected on the basis of pre-established theory
and observation. It is perhaps surprising that so few fac-
tor analysis studies on the Rome symptom criteria have
been conducted. The symptoms of irritable bowel syn-
drome (IBS) are consistently confirmed in paediatric and
adult patients exhibiting functional gastrointestinal
symptoms and in community samples [6-10]. The results
for functional dyspepsia are less consistent and may in-
volve separate subgroups [10-12].
Despite the high prevalence in ED patients of various
gastrointestinal (GI) symptoms consistent with the FGIDs
[3], it is not established that these symptoms are truly rep-
resentative of FGIDs as classified by the accepted stan-
dard, namely the Rome criteria. In other words, it is not
known whether the GI symptoms commonly found in EDCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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patients. This question is clinically relevant, because
gastroenterologists and other physicians are frequently re-
ferred patients with ED who have gastrointestinal
symptoms. If the GI symptoms in this patient group are
known to often represent functional GI disorders, as in
the general community, and notwithstanding the fact that
each patient requires an individual approach, the extent of
GI investigation may not need to be as comprehensive as
otherwise.
We hypothesized that the specific behaviors, psycho-
pathology and body image concerns characteristic of ED
patients would change the clustering or association of
GI symptoms, as described by the Rome classification,
from that present in non-ED patients and in community
samples. The aim of this study was therefore to deter-
mine, using factor analysis (FA), whether the GI
symptoms that are common in ED patients, hold true to
the Rome II FGID classification. Factor analysis was used
as it takes into consideration the variability among
observed variables. It examines what items correlate to-
gether in a multidimensional way and attempts to find
an unknown underlying factor that can explain the va-
riability. In other words, FA attempts to find homo-




185 consecutive eating disorder inpatients admitted to a
specialised Unit, specifically for treatment of their eating
disorder, in Sydney, Australia, were studied. Eating dis-
order DSM-IV diagnoses were: anorexia nervosa (N = 84),
bulimia nervosa (N = 33) and eating disorder not other-
wise specified (EDNOS, N = 68). Comorbidities were low,
and included treated diabetes type 1 (N = 2), polycystic
ovarian syndrome (2), treated celiac disease (1), and
treated bipolar depression (3). All patients otherwise
underwent routine clinical evaluation including blood
tests (hematology, biochemistry, and thyroid function)
and specific investigations to exclude organic gastrointes-
tinal disease where appropriate. All patients gave informed
consent. Ethical approval for the study was given by the
Northside Clinic Human Ethics Committee.
Questionnaire
All patients completed the Rome II Modular Question-
naire [5] shortly after admission to hospital. The question-
naire was scored to determine the presence of the Rome
II FGID symptom-based diagnoses for the three months
prior to admission. Patients did not routinely undergo
physiologic testing for a formal diagnosis of those FGIDs
requiring such testing, but the symptom criteria were
consistent with that particular diagnosis. Patients alsocompleted the Eating and Exercise Examination (EEE)
[13]; this included age (years), current and lowest ever
BMI kg/m2, and eating disorder behaviors, namely objec-
tive binge eating, self-induced vomiting, laxative use and
excessive exercise. Behaviors were recorded in average
days present in the previous 3 months. The definition of
objective binge eating was greater than 7 serves of food
eaten, associated with feelings that the eating was out of
control. The definition of excessive exercise was exer-
cising on greater than 19 days out of 28 days, and was
calculated using information on both intensity and du-
ration (kcal/15 mins) [14].
Data and statistical analysis
The Rome II questionnaire contains 157 items, which
would require a very large sample size if all variables
were included in the factor analysis. For this reason,
measures were taken to reduce the number of variables
included in the factor analysis. Specifically, only items
showing adequate response variation, defined as symp-
tom presence between 30 and 70% were retained. It is
typical to have a ratio of 10 subjects for each item
included in a factor analysis [15], and this was the case
in the current study after the item pool was reduced.
Principal components analysis using varimax rotation
was conducted on the responses to the remaining 17
questions (detailed in Table 1). Sampling adequacy was
assessed using the Kaiser-Meyer-Olkin (KMO) statistic
and the strength of the relationship amongst the
variables with Bartlett’s Test of Sphericity.
Factor scores were calculated for each patient for each
of the derived factors, and these were correlated against
BMI and behavior frequency scores using Spearman
correlations. For the behavior scores the average number
of days (out of 28) the behavior was present was
converted to a 0 to 4 scale (0 = no days, 1 = 1-7 days,
2 = 8-14 days, 3 = 15-21, 4 = 22-28 days). Differences on
factor scores between those with or without a specific
individual FGID (e.g. IBS, functional bloating or pel-
vic floor dyssynergia [PFD]) or FGID regional category
(e.g. functional oesophageal disorder), or between ED
diagnostic groups (anorexia nervosa vs bulimia nervosa
vs EDNOS), was explored using ANOVA. Because the
specific individual and regional FGID categories, and the
factor scores, were all based on Rome II data, alpha was
set at a more conservative 0.01 for these latter analyses.
All analyses were conducted using SPSS v19 and alpha
was set at 0.05 (except for the relationship between
FGID and factor scores).
Results
The clinical details and ED behaviors of the patients are
shown in Table 2. The prevalences of regional FGID
Table 1 Frequency of positive responses to ROME II questions and the factor loadings for the five factors identified
using factor analysis*

















38-2 Anorectal Unable to empty 98 53.0 .765 .136 .107 .137 .104
24-10 Bowel
disorder
Blocked sensation 96 51.9 .753 .221 .160 .004 .009
38-3 Anorectal Difficulty relaxing 61 33.0 .720 -.045 .058 .148 .068
24-7 Bowel
disorder
Incomplete emptying 112 60.5 .705 .110 .177 -.053 -.003
38-1 Anorectal Straining 114 61.6 .652 .110 .221 .052 .065
24-11 Bowel
disorder










83 44.9 .183 .779 .350 .049 .224
23 Bowel
disorder
Change in stool form when
discomfort starts
79 42.7 .279 .744 .200 .180 .137
12-2 Gastro-
duodenal
Bloating sensation of upper
abdomen





95 51.4 .209 .277 .747 .030 .235
13 Gastro-
duodenal
Pain stop after bowel
movement
55 29.7 .116 .307 .711 -.015 -.038
18 Gastro-
duodenal
Make self vomit 85 45.9 .071 .093 .000 .963 .089
17 Gastro-
duodenal
Vomiting episodes 89 48.1 .048 .129 -027 .963 .098
8 Esophageal Heartburn 65 35.1 -.012 .098 .092 .101 .872
6 Esophogeal Chest pain 67 36.2 .064 .069 .028 .042 .869
15 Gastro-
duodenal
Burp/belch 79 42.7 .213 .113 .065 .374 .417
* Factor loadings for the ROME II questions contained in each factor are shown in bold. Only loadings > 0.500 are considered significant loading on a factor.
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functional gastroduodenal disorder 31 (17%), functional
bowel disorder 159 (86%), functional abdominal pain 7
(5%), and functional anorectal disorder 63 (34%). The
prevalences of the most common specific FGIDs were:Table 2 Clinical details and behaviors of 185 eating
disorder patients for 3 months prior to admission to
hospital
Clinical details Mean SD
Age (years) 24.6 8.4
Current BMI (kg/m2) 18.3 3.6
Lowest ever BMI (kg/m2) 15.7 2.7
Behaviors N %
Restricting food intake daily 183 98.9
Objectively binge eating ( >once/week) 50 27.0
Inducing vomiting (>once/week) 78 42.2
Laxative use (>once/week) 21 16.8
Excessively exercising (> 5 days/week) 39 19.5functional heartburn 43 (23%), IBS 77 (42%), functional
abdominal bloating 58 (31%), functional constipation 49
(27%), functional proctalgia fugax 37 (20%), and pelvic
floor dyssynergia 10 (5%).
Factor analysis of the patients’ Rome II responses
revealed five factors explaining 68% of the variance. This
was confirmed by Scree plot. The KMO was 0.76 and
Bartlett’s test of Sphericity was significant (p < 0.001).
The five factors were termed ‘oesophageal discomfort’,
‘self-induced vomiting’, ‘bowel dysfunction’, ‘abdominal
discomfort’, and ‘pelvic floor dysfunction’. The factors,
the factor loadings and the percentage of patients
responding positively to the Rome II questions that
contributed to each factor are shown in Table 1.
The percentage of patients responding positively to all
questions for each of the factors was: ‘pelvic floor dys-
function’ 22% (5 questions, as ‘need to press’ loading
<0.500), ‘bowel dysfunction’ 34% (3 questions), ‘abdominal
discomfort’ 20% (3 questions), ‘self-induced vomiting’
46% (2 questions) and ‘oesophageal discomfort’ 27%
Table 3 Correlations of factor loadings with current BMI and behaviors present in previous 3 months
Factors Current
BMI
Eating disorder behaviors in previous 3 months
Objective binge eating Self-induced vomiting Laxative use Amount exercise
Pelvic floor dysfunction .193**
Bowel dysfunction .255**
Abdominal discomfort .195**
Vomiting .330*** .458*** .800*** .188*
Oesophageal discomfort .212**
*p < 0.01, **p < 0.005, ***p < .001.
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reported at least 3 of the 5 questions as present.
There were no significant associations of the factor
scores with the patient diagnoses, except for the self-
induced vomiting factor where bulimia nervosa was
significantly different from the anorexia nervosa and
EDNOS patients (F(2,182) = 11.550, p < 0.001).
Correlations of the factors with the behaviors and
current BMI are shown in Table 3. ‘Oesophageal discom-
fort’ correlated only with excessive exercise, ‘self-induced
vomiting’ correlated with binge eating, laxative use and
current BMI, while the other three factors correlated only
with laxative use. Relationship with the FGID categories
and post hoc ANOVA with IBS, functional abdominal
bloating and pelvic floor dyssynergia are shown in Table 4.Discussion
Contrary to our hypothesis, the main finding of this
study was that the Rome II classification of specific
FGIDs and of FGID regional categories generally holds
up to factor analysis of the GI symptoms present in a
large sample of ED patients. This was particularly evi-
dent for the specific FGIDs of pelvic floor dyssynergia,
IBS, functional abdominal bloating and functional cons-
tipation, and for three of the FGID regional catego-




















F values *p < 0.01, **p < 0.005, ***p < 0.001.
# No significant results for FGID categories: gastroduodenal disorders and abdominbowel disorders and functional anorectal disorders. The
one exception was the functional gastroduodenal ca-
tegory. Because ED patients exhibit behaviors and psy-
chopathology distinct from non-ED populations, we had
hypothesized that the range of GI symptoms prevalent
in this group may not conform to the Rome classifica-
tion of the FGIDs. The clinical relevance of our results is
that the GI symptoms in ED patients, once appropriate
investigations have been performed as indicated, are very
likely to represent the same FGIDs seen in non-ED
patients.
The factor we termed ‘oesophageal discomfort’
emerged as a separate factor, and consisted of heartburn
and chest pain of presumed oesophageal origin. This fac-
tor was associated with excessive exercise only and this
is entirely consistent with reports of heartburn and chest
pain, and disorders such as gastroesophageal reflux and
altered oesophageal motility, occurring in runners [16].
The factor ‘self-induced vomiting’ was to be expected in
this sample of ED patients, and not surprisingly was
more common in patients with bulimia nervosa, as this
phenomenon is included in the diagnostic criteria for
ED. In the Rome II questionnaire, if vomiting is self-
induced it is discounted for the diagnosis of functional
vomiting. This factor, not part of the Rome classification,
was associated with vomiting questions only and not
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tion’ and ‘abdominal discomfort’ were both significantly
associated with the FGID category of functional bowel
disorder. The factor termed ‘bowel dysfunction’ related
to a change in stool pattern rather than bloating and
appeared to be consistent with IBS. This is confirmed
by the highly significant relationship between ‘bowel
dysfunction’ and IBS (Table 4). The factor ‘abdominal
discomfort’, although also associated with IBS, was spe-
cifically associated with the FGID category of anorectal
disorder. This finding is consistent with our recent
report of a relationship between prolonged rectal balloon
expulsion time and abdominal distension in patients
with constipation [17]
The factor we termed ‘pelvic floor dysfunction’ is con-
sistent with the FGID category of functional anorectal
disorders and with the specific FGID of pelvic floor
dyssynergia. In the Rome II criteria, a diagnosis of pelvic
floor dyssynergia requires a concomitant diagnosis of
functional constipation, while a diagnosis of functional
constipation cannot be made if IBS is present. It can be
therefore difficult to obtain a diagnosis of pelvic floor
dyssynergia, especially when IBS is so common among
ED patients. In this study, however, factor analysis has
revealed 5 questions usually associated with pelvic floor
dyssynergia and functional constipation to cluster to-
gether independent of the presence or absence of IBS.
An alternative term for the pelvic floor dysfunction fac-
tor could have been functional obstructed defecation or
anismus, as we have no information about urinary or
vaginal pelvic floor problems in these patients. Anismus
is a form of functional obstructed defecation and can
cause constipation [18] and painful defecation. It is more
common in women than in men, and sometimes is asso-
ciated with sexual abuse [19].
Finally, the correlation of laxative abuse with most of
the factors is likely to reflect the higher prevalence of
laxative use and abuse among ED patients before admis-
sion to hospital for treatment of their eating disorder.
However there is little information about laxative use in
other FGID populations.
Conclusions
Factor analysis of gastrointestinal symptoms in ED pa-
tients is generally consistent with the Rome II classifica-
tion of FGIDs. Our findings, in a different patient group,
therefore support the validity of this symptom-based
classification. These results are also clinically relevant, in
that they provide the strongest evidence to date that the
GI symptoms common in patients with ED indeed
reflect the presence of FGIDs. However, pelvic floor
symptoms in the absence of functional constipation and
separate from IBS, are a prominent feature of ED
patients. These symptoms therefore warrant furtherresearch, and should be evaluated in different popu-
lations, including women in the community.
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